Maria Weir
Adult Health · Chesterfield, MONPI 1033485917
Payments from drug & device makers
Across 172 payments — averaging $23.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$711
- Sequel Med Tech, LLC$299
- Medtronic$209
- AstraZeneca$205
- BETA Bionics, Inc.$203
- Bayer$199
- plus $2K from 32 others
Across 16 payments — averaging $107.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Food & beverage$4,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $711 |
| Sequel Med Tech, LLC | 12 | $299 |
| Medtronic | 5 | $209 |
| AstraZeneca(2 entities) | 5 | $205 |
| BETA Bionics, Inc. | 2 | $203 |
| Bayer | 11 | $199 |
| Boehringer Ingelheim | 8 | $153 |
| AbbVie | 8 | $139 |
| Lilly USA, LLC | 8 | $138 |
| Insulet Corporation | 2 | $136 |
| Xeris Pharmaceuticals, Inc. | 7 | $136 |
| Abbott | 7 | $136 |
| Tandem Diabetes Care, Inc. | 1 | $115 |
| Mannkind Corporation | 6 | $104 |
| Novartis | 6 | $97 |
| Amgen | 5 | $92 |
| Radius Health, Inc. | 4 | $89 |
| IBSA Pharma Inc. | 4 | $82 |
| Merck | 5 | $80 |
| Amarin Pharma, Inc. | 5 | $77 |
| Corcept Therapeutics | 3 | $76 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Kyowa Kirin, Inc. | 3 | $72 |
| Ascensia Diabetes Care US Inc. | 3 | $54 |
| Ascendis Pharma Endocrinology Inc | 2 | $43 |
| Amphastar Pharmaceuticals, Inc. | 2 | $33 |
| Lexicon Pharmaceuticals, Inc. | 2 | $33 |
| Nevro Corp. | 2 | $32 |
| Antares Pharma, Inc. | 2 | $31 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Zealand Pharma US, Inc. | 1 | $23 |
| Halozyme Inc | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Lifescan, Inc. | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
| Intuity Medical Inc | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$571
- TWIIST$149
- MINIMED 780G$129
- RYBELSUS$122
- Omnipod$116
- t:slim X2 Insulin Pump with Control-IQ$115
- Ozempic$114
- FARXIGA$103
How this compares
$4,006 in reported general payments places this provider in the 85th percentile of 555 adult health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $84,351 |
| MounjaroTirzepatide | 56 | $80,740 |
| JardianceEmpagliflozin | 22 | $22,399 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $16,549 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 12 | $4,693 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,368 |
| SynthroidLevothyroxine Sodium | 19 | $1,366 |
| Metformin Hcl ErMetformin Hcl | 53 | $507 |
| Ezetimibe | 13 | $368 |
| Metformin Hcl | 33 | $236 |
| Levothyroxine Sodium | 13 | $63 |
| Glimepiride | 17 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $711 | $84,35150 claims |
| Lilly USA, LLCMounjaro | $138 | $80,74056 claims |
| Boehringer IngelheimJardiance | $153 | $22,39922 claims |
| AbbVieSynthroid | $139 | $1,36619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 555 adult health providers in Missouri.
Other adult health in Chesterfield
- Tabitha StithChesterfield$300K
- Racquel FrisellaChesterfield$110K
- Patrick BehnkeChesterfield$54K
- Kelly BeckChesterfield$8K
- Jamie JoyChesterfield$7K
- Kaitlin ThorsonChesterfield$6K
- Julie LambertChesterfield$5K
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.